261 related articles for article (PubMed ID: 10459544)
1. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
Drachenberg CB; Klassen DK; Weir MR; Wiland A; Fink JC; Bartlett ST; Cangro CB; Blahut S; Papadimitriou JC
Transplantation; 1999 Aug; 68(3):396-402. PubMed ID: 10459544
[TBL] [Abstract][Full Text] [Related]
2. Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study.
Park JB; Kim SJ; Oh HY; Han YS; Kim DJ; Park JW; Kwon CH; Joh JW; Lee SK
Transpl Int; 2006 Jun; 19(6):478-84. PubMed ID: 16771869
[TBL] [Abstract][Full Text] [Related]
3. FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat.
Yasunami Y; Ryu S; Kamei T
Transplantation; 1990 Apr; 49(4):682-6. PubMed ID: 1691535
[TBL] [Abstract][Full Text] [Related]
4. Functional and morphological study of cultured pancreatic islets treated with cyclosporine.
Ajabnoor MA; El-Naggar MM; Elayat AA; Abdulrafee A
Life Sci; 2007 Jan; 80(4):345-55. PubMed ID: 17074365
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive effect in combination therapy of cyclosporine A, FK506 and 15-deoxyspergualin on a pancreatic islet xenotransplantation].
Ueno M; Nakajima Y; Kanehiro H; Yoshimura A; Nakano H
Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):376-82. PubMed ID: 7686615
[TBL] [Abstract][Full Text] [Related]
6. Use of FK 506 in pancreas transplantation.
Gruessner RW; Sutherland DE; Drangstveit MB; Troppmann C; Gruessner AC
Transpl Int; 1996; 9 Suppl 1():S251-7. PubMed ID: 8959841
[TBL] [Abstract][Full Text] [Related]
7. Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro.
Waschulewski IH; Hall DV; Kern HF; Edwardson JM
Br J Pharmacol; 1993 Apr; 108(4):892-900. PubMed ID: 7683567
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.
Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW
Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function.
Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Gebel H; Williams JW
Transplantation; 1997 Mar; 63(5):716-21. PubMed ID: 9075844
[TBL] [Abstract][Full Text] [Related]
12. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation.
Fernandez LA; Lehmann R; Luzi L; Battezzati A; Angelico MC; Ricordi C; Tzakis A; Alejandro R
Transplantation; 1999 Nov; 68(10):1532-41. PubMed ID: 10589951
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation.
Griffith BP; Bando K; Hardesty RL; Armitage JM; Keenan RJ; Pham SM; Paradis IL; Yousem SA; Komatsu K; Konishi H
Transplantation; 1994 Mar; 57(6):848-51. PubMed ID: 7512292
[TBL] [Abstract][Full Text] [Related]
14. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.
Bartlett ST; Schweitzer EJ; Johnson LB; Kuo PC; Papadimitriou JC; Drachenberg CB; Klassen DK; Hoehn-Saric EW; Weir MR; Imbembo AL
Ann Surg; 1996 Oct; 224(4):440-9; discussion 449-52. PubMed ID: 8857849
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells.
Cilião HL; Ribeiro DL; Camargo-Godoy RB; Specian AF; Serpeloni JM; Cólus IM
Exp Toxicol Pathol; 2015 Feb; 67(2):179-87. PubMed ID: 25541063
[TBL] [Abstract][Full Text] [Related]
16. The direct effects of tacrolimus and cyclosporin A on isolated human islets: A functional, survival and gene expression study.
Bugliani M; Masini M; Liechti R; Marselli L; Xenarios I; Boggi U; Filipponi F; Masiello P; Marchetti P
Islets; 2009; 1(2):106-10. PubMed ID: 21099257
[TBL] [Abstract][Full Text] [Related]
17. Application of low dose of FK506 in pancreas transplantation model in Wistar-SD rats.
Li F; Wang SX; Li QY; Yin HS
Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):673-8. PubMed ID: 22283636
[TBL] [Abstract][Full Text] [Related]
18. [Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus].
Ippoliti GB; Viganò M
G Ital Nefrol; 2003; 20 Suppl 25():S11-4. PubMed ID: 14523907
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
20. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
